VRDN
Viridian Therapeutics Inc.
$21.33
+$0.34(+1.62%)
65
Overall
60
Value
91
Tech
44
Quality
Market Cap
$1.59B
Volume
420.54K
52W Range
$9.90 - $27.20
Target Price
$39.47
Key Metrics Overview
| Market Cap | $1.59B | P/E Ratio | N/A |
| 52W High | $27.20 | 52W Low | $9.90 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 22.8% | 52W Position | 66.1% |
| Overall Score | 65 | Value Score | 60 |
| Quality Score | 44 | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $-3.77 | EPS Next Est | $-4.07 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $21.33 | +1.6% | 420.54K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW